Explore

Rapid Read Rapid Read
Proteomics Identifies Carboxypeptidase E as Potential Biomarker for Synucleinopathies

Proteomics Identifies Carboxypeptidase E as Potential Biomarker for Synucleinopathies

Researchers have identified carboxypeptidase E (CPE) as a potential biomarker for synucleinopathies, including Parkinson’s disease, through proteomic analysis. This discovery, published in npj Parkinson’s Disease, highlights CPE's role in processing peptide hormones and neuropeptides, which may be disrupted in these disorders. Synucleinopathies are characterized by the accumulation of misfolded alpha-synuclein, leading to diverse symptoms and disease progression. The identification of CPE could aid in earlier diagnosis and more precise differentiation of related disorders, potentially improving clinical outcomes.
Trendline Trendline
Amgen Expands Global Research with New R Center in Hyderabad

Amgen Expands Global Research with New R Center in Hyderabad

Amgen Expands Global Research with New R Center in Hyderabad
Trendline Trendline
Eli Lilly Advances Spatial Biology and Genomics for Oncology Drug Discovery

Eli Lilly Advances Spatial Biology and Genomics for Oncology Drug Discovery

Eli Lilly Advances Spatial Biology and Genomics for Oncology Drug Discovery
Rapid Read Rapid Read
Study Validates Transcriptomic Changes in Type 1 Diabetes Progression

Study Validates Transcriptomic Changes in Type 1 Diabetes Progression

A recent study has validated the existence of biological heterogeneity in the progression of type 1 diabetes (T1D) through transcriptomic analysis. Researchers analyzed data from a follow-up cohort of 168 individuals with newly diagnosed T1D, confirming previous findings of gene expression changes associated with disease progression. The study identified numerous genes that were differentially expressed during the first year after diagnosis, with rapid disease progression linked to younger age and decreased neutrophil abundance. These findings suggest that early post-diagnosis blood transcriptomic changes can reflect underlying disease heterogeneity and are associated with subsequent loss of β-cell function.
Rapid Read Rapid Read
Mount Sinai Researchers Map Brain Immune Cells to Understand Alzheimer's Progression

Mount Sinai Researchers Map Brain Immune Cells to Understand Alzheimer's Progression

Researchers from the Icahn School of Medicine at Mount Sinai have published a comprehensive map of brain immune cells, highlighting their role in Alzheimer's disease. The study, published in Nature Genetics, identifies a protective subtype of microglia that becomes more abundant as Alzheimer's progresses. These cells help clear harmful material from the brain, and their protective state is maintained through a molecular pathway involving proteins TREM2, MITF, and GPNMB. The research analyzed over 830,000 myeloid-origin immune cells from the prefrontal cortex of 1,607 donors, providing insights into how these cells change with aging and disease progression.
Rapid Read Rapid Read
Innovative Injectable Device Offers New Hope for Chronic Pain Treatment

Innovative Injectable Device Offers New Hope for Chronic Pain Treatment

Researchers at New York University Abu Dhabi and Cleveland Clinic Abu Dhabi have developed a tiny injectable device that can wirelessly control nerves, offering a less invasive alternative to surgery for treating chronic pain and neurological conditions. The device, about the size of a small seed, is powered wirelessly from outside the body and can precisely control nerve activity. Laboratory and animal testing have shown that the device can reliably activate nerves and control muscle movement, although further improvements are needed for long-term stability and clinical use.
Rapid Read Rapid Read
Stanford Researchers Identify New Role for Tau Protein in Alzheimer's Disease

Stanford Researchers Identify New Role for Tau Protein in Alzheimer's Disease

Researchers at Stanford Medicine have discovered a new mechanism by which the tau protein, a central target in Alzheimer's drug development, damages brain cells. The study, published in Neuron, reveals that tau can infiltrate mitochondria, reversing the normal electron flow and generating reactive oxygen species, leading to cellular stress and inflammation. This discovery suggests a potential new drug target for Alzheimer's treatment. The research indicates that blocking this reversal can reduce neurodegeneration and improve learning and memory in animal models. Despite these findings, current Alzheimer's treatments remain unchanged, and no marketed supplements or interventions have been proven to affect the disease.
Rapid Read Rapid Read
Machine Learning Enhances Blood-Based Alzheimer's Biomarker Detection

Machine Learning Enhances Blood-Based Alzheimer's Biomarker Detection

Researchers have applied machine learning to blood proteomics data to improve Alzheimer's disease biomarker detection. The study, published in JAMA Neurology, utilized a novel immunoassay platform measuring over 120 inflammation and neuronal markers. By including additional proteins, the ability of p-tau217 to predict advanced tau pathology was significantly enhanced. This approach aims to improve the assessment of disease stage and progression, offering a more comprehensive understanding of Alzheimer's pathology.
Rapid Read Rapid Read
Noninvasive Brain Stimulation Shows Promise in Improving Parkinson's Nonmotor Symptoms

Noninvasive Brain Stimulation Shows Promise in Improving Parkinson's Nonmotor Symptoms

A study led by Korea University Ansan Hospital has demonstrated that transcranial direct current stimulation (tDCS) can significantly improve nonmotor symptoms in Parkinson's disease patients. The research involved 20 patients who underwent 10 sessions of tDCS, resulting in notable improvements in depression, anxiety, and apathy. The study also incorporated wearable technology to monitor changes in patients' physical activity, revealing increased daily activity levels post-treatment. These findings suggest that tDCS, a noninvasive neuromodulation therapy, could be a safe and effective adjunctive treatment for Parkinson's disease.
Trendline Trendline
Single-Cell Formation Cartridge Market Expands with Rising Demand for RNA Sequencing

Single-Cell Formation Cartridge Market Expands with Rising Demand for RNA Sequencing

Single-Cell Formation Cartridge Market Expands with Rising Demand for RNA Sequencing
Rapid Read Rapid Read
Discovery of Molecular 'Handshake' Offers Insight into Inflammatory Diseases

Discovery of Molecular 'Handshake' Offers Insight into Inflammatory Diseases

Three independent research teams have discovered a molecular interaction that controls a family of inflammatory diseases, including Familial Mediterranean Fever (FMF). This 'handshake' between the proteins CDC42 and pyrin is crucial for immune system regulation. A mutation in CDC42 causes it to bind too tightly to pyrin, leading to excessive immune responses and symptoms like fever and rash. This discovery has led to effective treatment with anakinra, a drug that blocks the specific inflammatory signal involved, providing relief for affected families.
Trendline Trendline
HanchorBio and Taiwan Cancer Moonshot Project Collaborate to Advance Precision Oncology

HanchorBio and Taiwan Cancer Moonshot Project Collaborate to Advance Precision Oncology

HanchorBio and Taiwan Cancer Moonshot Project Collaborate to Advance Precision Oncology